ORGENTEC, founded in 1988 and headquartered in Mainz, Germany, is a global leader in the development, production, and distribution of specialty autoimmune and infectious disease immunoassays for laboratory diagnostics.

In September 2021, Sebia acquired ORGENTEC. Sebia is a specialized In Vitro Diagnostic company and the world’s leading provider of clinical protein electrophoresis equipment and reagents for the screening and monitoring of various diseases.

With more than 1000 employees worldwide Sebia and now ORGENTEC, is present in more than 120 countries with more than 17 subsidiaries and representative offices.

Over the years ORGENTEC has continuously strengthened its international footprint to better serve its customers. ORGENTEC is proud of our unique and comprehensive autoimmune and specialty diagnostics portfolio. In total, ORGENTEC is offering more than 200 assays for Alegria^®, ELISA, Immunofluorescence and Immunoblot technologies. More than 130 different Alegria^® Monotest assays are available.

We are setting high standards with deep autoimmune expertise and scientific knowhow to make a difference and enable laboratory to diagnose complex autoimmune disease.

More information is available at: https://www.orgentec.com/en/